CMS

CMS Energy Corporation
NYSEUTILITIESUTILITIES - REGULATED ELECTRIC

Key Statistics

Market Cap
$23.54B
P/E Ratio
21.34
EPS
$3.57
Beta
0.34
52W High
$79.74
52W Low
$67.61
50-Day MA
$74.15
200-Day MA
$73.92
Dividend Yield
2.85%
Profit Margin
12.60%
Forward P/E
20.12
PEG Ratio
3.00

About CMS Energy Corporation

CMS Energy (NYSE: CMS), based in Jackson, Michigan, is an energy company that is focused principally on utility operations in Michigan.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$8.82B
Gross Profit (TTM)$3.58B
EBITDA$3.05B
Operating Margin19.80%
Return on Equity10.40%
Return on Assets3.13%
Revenue/Share (TTM)$29.17
Book Value$29.92
Price-to-Book2.60
Price-to-Sales (TTM)2.67
EV/Revenue4.89
EV/EBITDA12.70
Quarterly Earnings Growth (YoY)8.90%
Quarterly Revenue Growth (YoY)11.60%
Shares Outstanding$308.92M
Float$306.79M
% Insiders0.55%
% Institutions100.51%

Historical Volatility

HV 10-Day
25.03%
HV 20-Day
21.29%
HV 30-Day
23.59%
HV 60-Day
21.28%
HV Rank
100.0%

Volatility is currently expanding

Analyst Ratings

Consensus ($79.79 target)
3
Strong Buy
6
Buy
6
Hold
1
Strong Sell

Latest News

Tria Federal Appoints Former CMS and IRS CIO Rajiv Uppal to Advisory Board

ARLINGTON, Va., June 23, 2026 (GLOBE NEWSWIRE) -- Tria Federal today announced the appointment of Rajiv Uppal, former Chief Information Officer of the Centers for Medicare & Medicaid Services (CMS) and the Internal Revenue Service (IRS), to the company's Advisory Board.

GlobeNewsWire6/23/2026Neutral
CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World's First Bispecific Antibody for Passive Immunization Against Rabies

SHENZHEN, CHINA, June 22, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product has been approved by the National Medical Products Administration of the People's Republic of China (“NMPA”) and the drug registration certificate was obtained on 22 June 2026. The Product is indicated for passive immunization in adults following rabies virus exposure.

GlobeNewsWire6/22/2026Neutral
Goundafa Historic Mine Site Spring Work Program Completed

June 15 th , 2026 – TheNewswire - Muskoka Ontario – Steadright Critical Minerals Inc. (CSE: SCM ) (“Steadright” or the “Company”), is pleased to update shareholders on the historic polymetallic Copper-Zinc-Lead-Silver-Gold Mine , known as the Goundafa Mine, which has a fully permitted Mining License.  Steadright holds a Binding MOU on the site with $7.5 million USD remaining to purchase the shares of Ste Commerciale et Minière du Sahara(CMS) over the next 2.5 years. Steadright can accelerate payments through cash or common shares.   In April 2026 Steadright engaged Axiom Exploration Group Ltd. (“ Axiom ”), a global leader in integrated geoscience solutions, to support the rapid advancement of its diversified portfolio of high-potential critical mineral projects in Morocco. Axiom have recently been on site at the Goundafa Historic Minesite, after an unusual harsh winter.

TheNewswire6/15/2026Neutral
CMS proposes rule for Medicare drug price negotiations from 2029

The U.S. Centers for ​Medicare and ‌Medicaid Services has proposed a ​rule to ​establish a permanent ⁠framework for ​its Medicare drug ​price negotiation program starting in 2029, ​aiming to ​lower costs for million ‌of ⁠patients while providing drugmakers more certainty.

Reuters6/12/2026Negative

More UTILITIES Stocks

Data last updated: 7/9/2026